ArticleNature communications2025
Reconstituting transcription-translation-coupled DNA replication within complex in vitro biological systems.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Reconstructing transcription-translation-coupled DNA replication (TTcDR) in artificial systems is crucial for creating synthetic life; however, existing approaches face limitations mainly due to their reliance on purified biological components. Here, we introduce LoopReX, a cell-free system that reconstitutes TTcDR using crude Escherichia coli extracts, offering a more complex native biological environment. LoopReX leverages a minimal machinery composed of phi29 DNA polymerase and T7 RNA polymerase, with the latter facilitating DNA replication initiation through the generation of primer RNAs. Using machine learning, we optimize LoopReX to enhance the efficiency of both DNA replication and protein expression, achieving scalable, sustainable genetic flow and high-yield protein production with robust iterative performance. Furthermore, artificial nucleoids, autonomously formed through CipB-based compartmentalization, improve DNA spatial organization and support multiple biological functions. This work advances the construction of artificial life by reconstituting TTcDR within a single, scalable, and functionalized system, opening exciting possibilities for synthetic biology, biotechnology, and bio-hybrid applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.